News and Trends 19 Oct 2017 Meet some of the Hottest Startups of 2017! …Startup Slam in Barcelona, agrees with Mason wholeheartedly: “In my opinion every connection created during a conference or slam are relationships built and cultivated over time,” she says. “It’s probably… October 19, 2017 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Startup Scout 29 Mar 2019 This Biotech Repurposes Drugs to Fight Huntington’s Disease Barcelona-based SOM Biotech is developing treatments for incurable diseases such as Huntington’s disease with drugs that are already on the market for other diseases. Mission: To repurpose commercially available drugs… March 29, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Feb 2023 10 biotech companies making a difference in rare diseases …disorder characterized by immunodeficiency that leaves the body vulnerable to recurrent and severe infections. SpliceBio Headquarters: Barcelona, Spain Founded: 2012 SpliceBio is a biotechnology company looking to develop the next… February 28, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2018 A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for rare metabolic disorders like GM1 gangliosidosis. Gain Therapeutics is a new biotech that will… February 20, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Sponsored by Hub Organoids 12 Jul 2022 The organoid era: bringing patient-relevant preclinical models to the lab …HUB Organoids, OcellO B.V. (now Crown Bioscience) and Merus N.V., and international research institutions including the Hubrecht Institute, IRB Barcelona and the Sanger Institute. The Vall d’Hebron Institute of Oncology… July 12, 2022 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2025 Budget blues: where are cell and gene therapies heading? …Barcelona-based Splice Bio bagged €118 million ($139.66 million) in a series B financing round, which has created AAVs that overcome the challenges faced by traditional AAV vectors, which can only… September 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2017 Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is a biotech, which spun-out from the Catalan Institute of… November 13, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? …SpliceBio Headquarters: Barcelona, Spain Latest funding round: $135 million series B (June 2025) Lead candidate: SB‑007 for Stargardt disease (inherited macular degeneration) SpliceBio is developing a novel gene therapy technique… July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy …of the University of Rochester; Maria Carmo Fonseca of the University of Lisbon; Juan Valcarcel of the Center for Genomic Regulation in Barcelona; Tanja DeGruijl of the University of Amsterdam;… September 19, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2022 CanSinoBIO to present latest data on inhaled COVID vaccine …(WVC) Europe to be held October 11 to 14, 2022 in Barcelona, Spain. Jean-Denis Shu, vice president for medical affairs of CanSino Biologics will be presenting data to show Convidecia… October 5, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 30 Nov 2020 Can Anti-Aging Research Keep Us Healthy in the Long Run? …to underlie the aging process in many of our tissues. Barcelona-based company Senolytx aims to slow the aging process by removing these senescent cells from our tissues. “When we’re young,… November 30, 2020 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2020 Spanish Neurology Biotech Launches with €7.6M Series A Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis and Parkinson’s disease, has launched in Barcelona with a Series A of €7.6M. Alta Life… May 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email